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Abstract 
Phospholipase C (PLC) is a receptor-regulated enzyme that hydrolyses phosphatidylinositol 
4,5-bisphosphate (PI(4,5)P2) at the plasma membrane (PM) triggering three biochemical 
consequences, the generation of soluble inositol 1,4,5-trisphosphate (IP3), membrane–
associated diacylglycerol (DG) and the consumption of plasma membrane PI(4,5)P2. Each of 
these three signals triggers multiple molecular processes impacting key cellular properties. 
The activation of PLC also triggers a sequence of biochemical reactions, collectively referred 
to as the PI(4,5)P2 cycle that culminates in the resynthesis of this lipid. The biochemical 
intermediates of this cycle and the enzymes that mediate these reactions are topologically 
distributed across two membrane compartments, the PM and the endoplasmic reticulum (ER). 
At the plasma membrane, the DG formed during PLC activation is rapidly converted to 
phosphatidic acid (PA) that needs to be transported to the ER where the machinery for its 
conversion into PI is localised. Conversely, PI from the ER needs to be rapidly transferred to 
the plasma membrane where it can be phosphorylated by lipid kinases to regenerate 
PI(4,5)P2. Thus two lipid transport steps between membrane compartments through the 
cytosol are required for the replenishment of PI(4,5)P2 at the PM. Here, we review the 
topological constraints in the PI(4,5)P2 cycle and current understanding how these constraints 
are overcome during PLC signalling. In particular, we discuss the role of lipid transfer 
proteins in this process. Recent findings on the biochemical properties of a membrane-
associated lipid transfer protein of the PITP family, PITPNM proteins (alt. name RdgB/Nir 
proteins) that localize to membrane contact sites is discussed. Studies in both Drosophila and 
mammalian cells converge to provide a resolution to the conundrum of reciprocal transfer of 
PA and PI during PLC signalling.  
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Introduction 
Phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) is the most versatile inositol-containing 
phospholipid enriched at the inner leaflet of the plasma membrane (PM). PI(4,5)P2 levels 
govern many cellular functions including endocytosis, ion channels and transporter activity 
and cytoskeleton-PM interactions [1]. Additionally, PI(4,5)P2 is a substrate for two signalling 
pathways, phospholipase C (PLC) and phosphoinositide 3-kinase (PI3K). Both are ubiquitous 
cell signalling pathways that can be activated by agonists acting on appropriate cell surface 
receptors. Both G-protein-coupled receptors and receptor tyrosine kinases can regulate PLC 
activity. In addition, both pathways can also be activated by small GTPases and some PLCs 
by a rise in cytosolic Ca2+. Hydrolysis of PI(4,5)P2 by PLC generates two second messengers, 
diacylglycerol (DG) and inositol(1,4,5)trisphosphate (IP3). A secondary consequence of PLC 
activation is a transient reduction in PI(4,5)P2 levels and this can have a profound impact on 
cellular functions which depend on the intact lipid. Thus mechanisms have to be in place to 
replenish PI(4,5)P2 levels during cell signalling. This review focuses on these potential 
mechanisms.  
 
Phospholipase C-mediated signalling has a long history and the first papers were published in 
the 1950s when it was noted that activation of cells with appropriate agonists caused an 
increase in the labelling of phosphatidylinositol (PI) and phosphatidic acid (PA) when cells 
had been pre-incubated with 32Pi to label the ATP pool. This stimulated increase in PA and PI 
labelling was a ubiquitous phenomenon observed in a wide range of cell types (see Fig. 1). 
The time-course of PA and PI labelling indicated a product precursor relationship whereby 
PA was converted into PI and by 1964, the metabolic interconversion between PA and PI was 
established and became known as the ‘PI cycle’ (Fig. 1A) [2]. In 1975, it was proposed that 
the ‘PI cycle’ stimulated by agonist receptor interactions was responsible for causing the 
increase in cytosol Ca2+ [3]. Although much of the data fitted into this paradigm, there were 
clearly situations where Ca2+ was able to activate the ‘PI cycle’ [4]. The issue about Ca2+ and 
PLC activation was ultimately resolved when it became clear that there are multiple PLC 
isozymes with different characteristics. The ‘PI cycle’ was later modified to include PI(4,5)P2 
as the cellular substrate for the PLC rather than PI and is referred here as the ‘PI(4,5)P2 
cycle’. PI became an intermediate in the pathway and was converted into PI(4,5)P2 by two 
lipid kinases, PI 4-kinase and PIP 5-kinase (Fig. 1B). The discovery that IP3 was capable of 
mobilising Ca2+ from intracellular stores secured the link between the PI(4,5)P2 cycle and 
changes in cytosol Ca2+ [5]. The subsequent discovery of the IP3 receptor at the endoplasmic 
reticulum finally established the ‘PI(4,5P2 cycle’ as an important signal transduction system. 
In addition to generating IP3, the other product of PLC activation is DG. This lipid was also 
identified as a second messenger; it activates several proteins including protein kinase C by 
interactions with C1 domains. Thus PLC activation became established as a signal 
transduction system at par with adenylyl cyclase-cAMP second messenger system. It has 
subsequently become clear that the receptor activated PI(4,5)P2 cycle is a conserved feature 
of most metazoan cells.  
 
An outstanding question that was highlighted in a review in 1973 and again in 1975 was the 
issue of lipid transfer between the plasma membrane and the endoplasmic reticulum. PLC-
mediated PI(4,5)P2 hydrolysis was confined to the PM but the machinery to resynthesise PI 
was present at the endoplasmic reticulum (Fig. 1B) [3;6]. In 1974, a cytosolic activity had 
been identified that was able to transport PI between membrane compartments and the 
concept arose that lipids could be moved by ‘lipid transfer proteins’ (LTPs) [7]. The 
identification of soluble PITP as an exchange protein that could bind and transfer PI and 
phosphatidylcholine (PC) and subsequently shown to support IP3 production in permeabilised 
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cells established the principle that PITPs participated in lipid transfer during PLC signalling 
[8;9]. However, the outstanding issue for PA transport from the PM (where it is produced by 
the sequential action of PLC and DGK) to the ER (where it is channelled into PI resynthesis) 
remained unclear until recently. In 2012, we identified that some members of the PITP 
family, namely the RdgB proteins were able to bind and transfer PA in addition to PI [10]. 
This was the first example of a PA transfer protein. Previous experiments conducted in 
permeabilised cells where the PI resynthesis cycle was reconstituted indicated that PA 
transfer did not require cytosolic proteins or vesicular transport and it was suggested that PA 
transfer occurs at membrane contact sites [11]. Here we highlight the journey that has led to 
the identification of a class of PITPs (PITPNM/RdgB proteins) that can exchange PA for PI 
between the ER and the PM to complete the ‘PI(4,5)P2 cycle’. This journey has taken 40 
years. 
 
To a large extent, studies of the PI(4,5)P2 cycle have been performed in cell culture models. 
Although studies conducted in cell-lines where the individual components can be over-
expressed or knocked out have provided fundamental information about PLC signalling, there 
are limitations. Studies in cultured cell-lines have relied on over-expression of multiple 
proteins simultaneously including receptors to enhance PLC signalling, PITPNM proteins 
and probes targeted to specific membranes to monitor changes in lipids. In these studies, the 
PLC signalling pathway has been hyper-stimulated and moreover, do not take into 
consideration the expression levels of endogenous PITP proteins or receptors. Nonetheless, 
these studies provide a valuable insight into the PLC signalling pathway. The human body 
contains approximately 200 different cell-types that are specialised to perform specific 
functions. More importantly, the protein composition as well as protein abundance varies 
depending on cell type. Thus it is critical to examine PLC signalling in the context of a 
specific cell function. The study by Kruse et al [12] highlights the importance of studying 
PLC signalling under physiological conditions.  
 
The Drosophila phototransduction cascade remains one of the best characterized systems 
where the application of genetics coupled with measurements of the physiological output i.e. 
light response provides context to PLC signalling [13-16]. In these cells photon absorption by 
rhodopsin is transduced into opening of two classes of Ca2+-permeable ion channels, TRP and 
TRPL [13]. This transduction pathway requires Gq-mediated PLC activation leading to 
PI(4,5)P2 hydrolysis. Several generic elements of the ‘PI(4,5)P2 cycle’ including the G-
protein coupled receptor (rhodopsin encoded by ninaE), heterotrimeric G-protein (Gq), 
phospholipase C4 (PLC4 encoded by norpA), DG kinase (DGK encoded by rdgA), CDS 
(cds), PI synthase (pis) and PITPNM (encoded by rdgB) and PIP5K [reviewed in [13]] have 
been identified and characterized in fly photoreceptors. The ability to combine genetics with 
measurements of the physiological outcome has made Drosophila photoreceptors a valuable 
tool to dissect the questions related to the PI(4,5)P2 cycle.  Thus we will draw upon this 
system as an exemplar in our review and in many instances, provide a comparative analysis 
between studies in mammalian cell lines and Drosophila photoreceptors. 
 
 
Biochemistry of the PI cycle 
PI constitutes about 5-7 % of the total cellular phospholipids in mammalian cells. De novo 
synthesis of PI occurs at the ER from PA (see Fig. 1B). PA is synthesised by the acylation of 
glycerol-3-P (G3P) to lysophosphatidic acid (LPA) and a second acylation reaction to 
generate PA. The PA is converted to cytidine diphosphate diacylglycerol (CDP-DG) by the 
enzyme, CDP-DG synthase (CDS) in the presence of CTP. The final step is the condensation 
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of CDP-DG and myo-inositol into PI by PI synthase (PIS). An intriguing feature of PI in 
mammalian cells is its distinctive fatty acid composition; it is enriched in stearic acid (18:0) 
at the sn-1 position and arachidonic acid (20:4) at the sn-2 position of its glycerol backbone 
[17]. In mammalian cells, PI acquires its characteristic fatty acid composition by fatty acid 
remodelling after de novo synthesis of PI through sequential deacylation and reacylation 
reactions [18;19]. The mammalian enzyme responsible for the enrichment of arachidonic acid 
into PI is LPIAT (lyso-PI acyltransferase) (also known as MBOAT7) [17;20;21]. The 
importance of this fatty acid configuration is underscored by the observation that disruption 
of this gene in mice leads to severe defects in brain development including a substantial 
reduction in the levels of PI [17;21]. 
 
PI can be sequentially phosphorylated by PI 4-kinase (PI4K) to PI4P and finally to PI(4,5)P2 
by PIP 5-kinase (PIP5K). However, of the total cellular pool of PI, only 10-12 % is present in 
the phosphorylated forms with the PI4P and PI(4,5)P2 being the most abundant. The family of 
PI 3-kinases can also phosphorylate PI, PI4P and PI(4,5)P2 to make PI3P, PI(3,4)P2 and 
PI(3,4,5)P3 respectively but these species are present at much lower abundance [22]. PI4P 
and PI(4,5)P2 are both enriched at the PM although PI4P  is also found in other compartments 
including the Golgi, endosomes and lysosomes [23;24]. The seven phosphorylated 
derivatives of PI are enriched in specific membrane compartments due to the presence of 
unique lipid kinases and phosphatases that respectively add and remove phosphates from 
unique positions on the inositol ring. In many internal compartments, these phosphoinositides 
are interconverted by lipid kinases and phosphatases but in this case the basic backbone of PI 
is not destroyed. It is only the PLC signalling system that destroys the lipid requiring the 
resynthesis of PI.  
 
 
Biochemical constraints in the PI(4,5)P2 cycle 
One of the central assumptions of the ‘PI(4,5)P2 cycle’ is that the PA produced from PLC 
activity does not ‘mix’ with other cellular pools of PA and is maintained separately for 
recycling back to PI [3;25;26]. This assumption is partly based on observations that increased 
labelling of PI with [32P]Pi is not normally accompanied with enhanced labelling with radio-
labelled glycerol or fatty acids. Additionally, measurements of the fatty acid composition of 
newly-formed ‘stimulated PA’ reflects the fatty acid composition of PI i.e. PA formed is 
enriched in stearate and arachidonate. In principle, there are at least two other major 
pathways that can generate PA which can then enter the PI(4,5)P2 cycle. One of these is the 
de novo synthesis from glycerol and fatty acids. In the second pathway, PA can also be 
produced by the hydrolysis of phosphatidylcholine (PC) by phospholipase D (PLD). In 
mammalian cells there are two PLDs, PLD1 and PLD2 that are also activated when cell 
surface receptors bind their agonist [27]. It is not uncommon for both PLC and PLD to be 
activated by the same receptors. Since the fatty acid composition of PA derived from PLD 
activity will reflect the composition of PC, which mainly contains mono-saturated fatty acids, 
it is possible to distinguish the source of the PA [28] although recent studies with PLD2 
knockout mice have failed to verify this model [29]. There is some evidence to suggest that 
the backbone of PI(4,5)P2 is recycled back into PI and the PA from the PLD pathway is kept 
separate [11;26]. This question needs to be revisited in intact cells where selective inhibition 
of the PLD pathway could be used to address this question.  
 
Although the PI(4,5)P2 cycle is ubiquitous in distribution across cell types, it acquires 
complexity because the mammalian genome contains multiple genes that produce variants of 
a specific enzyme activity that can catalyse a specific step of the cycle. For example there are 
 6 
 
thirteen PLCs and ten DG kinases (excluding splice variants) in mammalian cells. As a 
further complexity, other lipid metabolising enzymes that are not core steps of the PI(4,5)P2 
cycle can also generate lipid intermediates of the cycle. For example, PA can be produced by 
phospholipase D (PLD1 and PLD2 and NAPE-PLD) [30;31] and DG can exit the cycle by 
being metabolised to 2-arachidonylglycerol (2-AG), an activator of the endocannabinoid 
receptor, by DG lipase. This is particularly important in the brain as postsynaptic 
synthesis and release of endocannabinoid lipids activate presynaptic cannabinoid1 receptor to 
mediate short and long term depression in many brain regions. In platelets, DG can exit the 
cycle by being metabolised by DG lipase  to form arachidonic acid for thromboxane synthesis 
[33]. Thus the assumption that the intermediates in the ‘PI(4,5)P2 cycle’ might be conserved 
[3] may not be valid. In platelets, mass measurements of phosphoinositides, PA and DG 
following stimulation with thrombin revealed that the loss of phosphoinositide was not 
completely recovered as either DG or PA [33]. What is clear is that hormone-stimulated PI 
resynthesis always occurs when PI(4,5)P2 hydrolysis by PLC takes place to replace the pool 
of degraded PI(4,5)P2 [3;34]. Below we describe the key enzymes that participate in the cycle 
and their sub-cellular locations. 
 
 
Phospholipase C 
Thirteen PLC enzymes have been identified and grouped into six classes, PLC1-4, 
PLCPLCPLCPLC and PLCon the basis of domain structure and 
regulatory mechanisms (Table 2). The presence of a catalytic X and Y domain, a PH domain, 
a C2 domain and 4 EF hands are the common features shared by these PLCs. The presence of 
additional subtype-specific domains contributes to specific regulatory mechanisms. The 
enzymes of the PLCfamily can be stimulated by G-protein-coupled receptors and the Gq 
family of G-proteins are responsible for their activation. PLCis regulated by Ras, G and 
by G12. Receptor tyrosine kinases, on the other hand, activate PLC1 and 2 whilst 
PLCfamilyPLC and PLCare regulated by a rise in cytosol Ca2+ from the nanomolar to 
the micromolar range. In vitro, PLCs can hydrolyse PI, PI4P and PI(4,5)P2 but it is thought 
that in cells, PI(4,5)P2 is their main substrate. However, there may be exceptions; for 
example, PLCis present at the vicinity of the nuclear envelope where it hydrolyses Golgi 
PI4P [35]. The majority of the PLCs have been deleted in the mouse individually and the 
animals exhibit a range of phenotypes including epilepsy (PLC1), embryonic lethality 
(PLC1) and B cell development defects (PLC) [36].  
 
Although the PLC signalling pathway was first characterised as a means to generate the 
second messengers, IP3 and DG, it is now clear that a decrease in PI(4,5)P2 also has 
significant consequences. The intact lipid, PI(4,5)P2 is a key regulator of many ion channels 
[37;38]. The best example is the regulation of the M-current carried by KCNQ2/3 (Kv7.2/7.3) 
potassium channels [39;40]. The M-current is activated by muscarinic receptors and depletion 
of PI(4,5)P2 causes the closure of these channels; IP3 and DG do not play a significant role. In 
a recent study, detailed analysis of two GPCRs present in the same cell, concluded that the 
number of receptors activated determined how much PI(4,5)P2 depletion occurred [41]. 
Interestingly, this concept has a longer history. Early studies had indicated that the ‘PI cycle’ 
tracked receptor occupancy but not changes in cytosol Ca2+ [42]. The recent studies used the 
M-current as a surrogate for PI(4,5)P2 hydrolysis, and substantial PI(4,5)P2 hydrolysis only 
occurred when receptors were present at a high density. Thus only activation of the high 
abundance muscarinic receptor led to closure of the KCNQ2/3 potassium channels but not by 
the activation of the low abundance P2Y2 receptors for ATP [12;38;41]. Nonetheless 
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activation of either receptor by saturating concentrations of agonist provoked a full amplitude 
Ca2+ response. This study confirms earlier work that only a small amount of PI(4,5)P2 needs 
to be hydrolysed to obtain a maximal rise in cytosol Ca2+. Secondly, a high receptor 
occupancy is required to obtain a substantial decrease of PI(4,5)P2. This is an important 
conclusion as it clarifies how different GPCRs in the same cell can produce different 
functional outputs. Further it implies that receptor density with maximal receptor occupancy 
will determine how much PI(4,5)P2 will get depleted.  Under these circumstances, the PI 
resynthesis pathway must be tuned to cope with the extra demand when PI(4,5)P2 depletion 
occurs following high rates of receptor-triggered PLC activity. In this setting, another 
important factor that needs consideration is the speed of PI(4,5)P2 replenishment. Is the rate 
of PI(4,5)P2 synthesis variable between different cell types? Comparing the dynamics of 
PI(4,5)P2 resynthesis following PLC signalling in sympathetic neurons and in a non-excitable 
cell line reveals that synthesis of PI4P is restored much faster in sympathetic neurons than in 
a non-excitable cell-line [12]. In neurons, PI(4,5)P2 has many essential functions including 
exocytosis, endocytosis, actin assembly and ion channel regulation and may be more 
vulnerable to PI(4,5)P2 depletion. This may require additional mechanisms to cope with the 
PI resynthesis pathway. The resynthesis of PI(4,5)P2 at the plasma membrane requires a 
supply of PI and it is here that lipid transporters may play an important role.  
 
In the Drosophila genome, there are only three PLCs; two are highly related to the PLC 
family, NORPA and Plc21C and a single PLC(Table 2)[43-47]. Unlike in mammals, loss 
of PLC does not lead to lethality but causes small wings [45]. Plc21C is implicated in 
olfaction transduction whilst NORPA is required for phototransduction. NORPA expression 
is enriched in photoreceptors and in these cells there are high levels of basal PLC activity 
[48]. Following illumination, PLC activity increases dramatically and under bright light 
condition ca. 1x106 PLC molecules are active [49]. Thus Drosophila photoreceptors are an 
example of cells in which very high rates of PLC activity are achieved. Despite these high 
levels of PLC activation, PI(4,5)P2 levels show only a 50% reduction under daylight 
equivalent illumination in vivo [50]. This was however not the case when recordings were 
done in the absence of extracellular Ca2+ or in the trp mutant which reduced Ca2+ influx into 
photoreceptors [50;51]. Thus the end point of PLC activation, namely Ca2+ influx may offer a 
mechanism by which PLC activity can be inhibited and tuned to prevent PI(4,5)P2 depletion. 
Interestingly a biochemical study of PLC activation in Drosophila heads has reported a bell 
shaped dependence of PLC activity on Ca2+ concentration [52]. 
 
A further question that arises is the mechanism by which specificity of PI(4,5)P2 signalling 
arises during PLC activation. PI(4,5)P2 has multiple functions at the plasma membrane and 
therefore during PLC signalling it is essential to have mechanisms that prevents the non-PLC 
dependent functions of PI(4,5)P2 being affected. There are multiple mechanisms by which the 
specificity of PI(4,5)P2 functions can be preserved; these have recently been reviewed [53]. 
In many neuronal and also some non-neuronal cells, many of the phospholipases form macro-
molecular complexes with other proteins during cell activation which means that PLC 
activation at the plasma membrane is likely to be restricted to microdomains. If PI(4,5)P2 
hydrolysis at these domains is tightly coupled to the local delivery of PI for replenishment, 
this would lessen the impact of PI(4,5)P2 depletion on other PI(4,5)P2 dependent systems.  
 
In Drosophila photoreceptors, NORPA is localized at the plasma membrane along with the 
GPCR, rhodopsin and Gq. In this location it is found as part of a macromolecular protein 
complex assembled on the multi-PDZ domain protein INAD. In addition to NORPA, this 
complex includes the TRP channel, PKC and NINAC, an unconventional myosin [reviewed 
 8 
 
in [16;54]]. The 90 a.a. PDZ domain was originally identified as a conserved element in three 
structurally unrelated proteins, PSD-95, DLG and ZO-1. The PDZ domain binds to short 
carboxy-terminal peptide sequences of target proteins. Multiple PDZ domains are often 
present in a single protein promoting the scaffolding of several target proteins [55]. All PLC 
subtypes have PDZ binding motifs and the PDZ-containing NHERF (Na+/H+ exchanger 
regulatory factor) family and SHANK proteins form signalling complexes bringing together 
the PLC isozymes with the different receptors [56]. Despite considerable interest in the idea 
that the presence of NORPA in the INAD complex of Drosophila photoreceptors provides 
speed and specificity to PLC signalling [57], a number of studies have failed to support the 
idea that the presence of an intact INAD complex is required for normal activation through 
PLC signalling [58;59]. However the notion that confining PLC activation to signalling 
platforms would avoid effects on the cytoskeleton and vesicular transport and allow 
channelling of substrate to these regions remains attractive. As discussed below, these 
signalling platforms could reside at membrane contact sites allowing for efficient and 
localised signalling to occur.  
 
 
Diacylglycerol Kinases 
The product of PLC activity is DG that is rapidly phosphorylated to PA by DGK. The first 
DG kinasewas cloned in 1990 and now there are ten DG kinases in the mammalian genome 
and five in the Drosophila genome (Table 2). DGK enzymes are subdivided into five 
subtypes based on the domain structures [60]. The expression of DGKs is cell-type specific 
[60]; for example, in T cells the predominant isoforms expressed are DGK and DGK. 
Since PI(4,5)P2 in mammalian cells is enriched in C18:0/C20:4, the DG formed will also 
have the same fatty acid composition. DGK has been shown to specifically utilise stearoyl 
arachidonyl glycerol [61]. However, this specificity is not absolute as all the other DGKs can 
utilise C18:0/C20:4 species.  
 
PA made following the activation of PLC activity is found at the plasma membrane as 
demonstrated using subcellular fractionation [62]. However DGK may not be constitutively 
localized at the plasma membrane. For example, in T cells the predominant isoforms 
expressed, DGK and DGK are both recruited to the plasma membrane following T-cell 
receptor activation where they contribute to the termination of DG-mediated signalling 
downstream following PLC activation by T cell receptor-ligand complexes [63;64]. An 
important consequence of this observation is that PA, the product of DGK activity being a 
lipid, will be spatially restricted to the PM while the next enzyme in the PI(4,5)P2 cycle, CDS 
that utilizes PA as a substrate, is localized to the ER. Thus a mechanism is required to 
transport PA from the PM to the ER. 
 
In Drosophila photoreceptors, the DGK that is utilised in the removal of DG after PLC 
activation is encoded by rdgA [65]. The mammalian equivalent of the RDGA protein is the 
type IV family that includes DGK and DGK. Loss of rdgA results in enhanced electrical 
responses to light, a defect in response termination [66;67] and severe retinal degeneration 
[68;69]. All of these phenotypes are dependent on ongoing PLC activity [reviewed in [13]] 
and underscore the importance of DGK in regulating light-induced PI(4,5)P2 turnover. The 
biochemical basis of phenotypes resulting from reduced rdgA function remains to be 
resolved. Reduction in rdgA function results in lower levels of PA; surprisingly elevated DG 
levels have not been demonstrated [70;71]. It has been proposed that the DG may be 
metabolised via liberation of polyunsaturated fatty acids (PUFA)  that may then activate TRP 
channels [reviewed in [72]]. An interesting feature of RDGA is that in photoreceptors, the 
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protein is localized to the sub-microvillar cisternae (SMC) [73], a specialization of the ER 
that forms a membrane contact site with the microvillar plasma membrane [reviewed in [74]] 
This localization of RDGA to an ER sub-compartment resembles, conceptually, the 
recruitment of DGK and DGK from the ER to the PM of mammalian cells following 
receptor-mediated PLC activation. In the case of Drosophila photoreceptors, RDGA could 
act in trans across the small 10 nm gap at this MCS to access DG generated at the microvillar 
plasma membrane by NORPA. 
 
Type II PA phosphatase   
Biochemical experiments have identified two phosphatidic acid phosphatase activities in 
mammalian cells. One of these, Type I PA phosphatase (also called Lipins), a Mg2+ 
dependent and N-ethylmaleimide-sensitive activity is associated with the cytosol and 
microsomal fraction and involved in phospholipid biosynthesis. The other, a Type II 
phosphatidic acid phosphatase (also called lipid phosphate phosphohydrolase, is Mg2+ 
independent and N-ethylmaleimide-insensitive and is associated with the plasma membrane 
(reviewed in [75]). This latter class of PA phosphatases have been suggested to be involved 
in regulating signalling reactions and may in principle regulate the PI(4,5)P2 cycle where PA 
is generated as an intermediate by DGK activity. However, although a role for Type II PA 
phosphatase in regulating PA levels in Drosophila is shown, its role in regulating  PI(4,5)P2 
levels in mammalian cells remains to be established. 
 
A Drosophila ortholog of Type II PA phosphatase has been implicated in the regulation of 
the PI(4,5)P2 cycle in Drosophila photoreceptors [71;76]. The Drosophila genome encodes 
seven Type II PA phosphatase-like genes. One of these lazaro (laza), in enriched in the eye. 
Loss of function mutants in laza show increased accumulation of PA during illumination that 
triggers G-protein coupled hydrolysis of PI(4,5)P2. rdgA (DG kinase) mutants show reduced 
levels of PA and these are further reduced by overexpression of laza. Importantly, in addition 
to PA, the levels of PI are also reduced in rdgA mutants and these are further reduced by 
overexpression of laza. Thus a Type II PA phosphatase activity regulates the levels of PA and 
PI, two key intermediates during G-protein coupled PLC activation in photoreceptors. The 
retinal degeneration and electrophysiological defect in rdgA can be enhanced by 
overexpression of laza and suppressed in rdgA;laza double mutants. Together these findings 
suggest that Type II PA phosphatase regulates PA and PI turnover during PLC activation. 
The sub-cellular localization of endogenous LAZA remains to be established. 
 
 
Cytidine diphosphate diacylglycerol synthase 
The next enzyme in the PI(4,5)P2 cycle is CDP-DG synthase (CDS) which catalyses the 
conversion of PA to CDP-DG, an essential intermediate step in the biosynthesis of PI. In 
mammals, two homologous genes of CDS (CDS1 and CDS2) have been cloned that are 73% 
identical and 92% similar [77-79]. Genes homologous to mammalian Cds are found in E. 
coli, S. cerevisiae, Drosophila, plants and cyanobacteria [79-81]. In S. cerevisiae, the single 
CDS1 is an essential gene and appears to account for the majority of the synthase activity 
[82] (but see later). In Drosophila, complete loss of CDS results in lethality. However an eye-
enriched isoform of CDS is expressed and mutant alleles that result in its downregulation 
result in defects in phototransduction and retinal degeneration [83]. In Drosophila 
photoreceptors, CDS is distributed throughout the cell body; it is likely localized to the ER as 
has been reported for mammalian cells [84;85].  
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The two isoforms of mammalian CDS show different substrate specificities. Mammalian 
CDS2 appears to be selective for the acyl chains of PA, the most preferred species being 1-
stearoyl, 2-arachidonoyl-sn-PA [84]. The fatty acid composition of PI and its phosphorylated 
derivative, PI(4,5)P2 is mainly 1-stearoyl, 2-arachidonyl, and during PLC signalling, the PA 
generated would retain this composition. This is also supported by studies in zebrafish where 
CDS2 controls the availability of PI(4,5)P2 for VEGF signalling, and when mutated, there is a 
failure of angiogenesis [86]. CDS1, on the other hand, shows no particular substrate 
specificity [84]. Expression studies indicate that CDS1 and CDS2 exhibit quite different 
tissue specificity. In the mouse, Cds2 appears to be ubiquitously expressed whilst CDS1 has a 
restricted pattern of expression.  
Early biochemical studies in yeast and mammalian cells showed that CDS activity was 
present in both microsomal (mainly ER) and mitochondrial fractions [87-89] hence CDS1 
was thought to be present in both ER and mitochondria. However, recent studies in yeast 
have identified a new enzyme, Tam41, which possesses CDP-DG synthase activity. Tam41 is 
a peripheral membrane protein localised in the inner mitochondrial membrane where it is 
involved in cardiolipin synthesis [90]. Tam41 and the yeast CDS1 have different evolutionary 
origins and are not related by sequence although both possess CDS activity [90]. It is of 
interest that the substrate, PA, is transported from the outer mitochondrial membrane to the 
inner mitochondrial membrane-localised Tam41 by the yeast PA transporter, Ups1/Mdm35 
complex (TRIAP1/PRELI complex in mammals) [91-95]. Interestingly, this complex has 
structural homology to mammalian PITP[96;97].  
 
 
PI synthase 
Phosphatidylinositol synthase (PIS) is involved in the final step of PI synthesis, converting 
CDP-DG and myo-inositol into PI. In addition to de novo biosynthesis, PIS has exchange 
activity where the inositol of the PI can be replaced for free inositol in the presence of Mn2+, 
in the absence of CDP-DG [98]. PIS activity localises mainly to the ER and molecular 
identification was first achieved in yeast and ultimately made it possible to clone the 
mammalian enzyme [79;99]. There is a single gene for PIS in yeast and in mammalian cells 
and share sequence identity throughout their primary sequence. The human PIS gene is 
predicted to encode for an integral protein of 213 a.a. (23 kDa) and studies in yeast indicate 
that the active site faces the cytosol [100]. In Drosophila, there is a single PIS gene (dPIS); 
loss of function mutants in dPIS result in both organismal and cell lethality underscoring the 
central role of PI signalling in eukaryotic cell biology. Hypomorphic alleles of dPIS show 
defects in phototransduction, a process that requires PI(4,5)P2 regeneration after its 
hydrolysis by PLC [101].  
 
The ER is a heterogeneous compartment and studies conducted in COS 7 cells indicate that 
that over-expressed PIS can co-localise with Rab10 to an ER-derived sub-compartment 
[85;102]. This sub-compartment makes contacts with other membranes implying that PI can 
be delivered to other membranes presumably by a lipid transfer mechanism. These dynamic 
structures required the GTPase Sar1, indicating that they were generated from the ER. 
However, CDS1 or 2 did not co-localise in these dynamic structures [85]. The dependence on 
Sar1 implies that the vesicles are initially made as COPII-coated vesicles. One possibility is 
that PIS, normally an ER-resident enzyme, when over-expressed at high levels results in 
being captured into COPII vesicles. The fundamental issue would be access to CDP-DG for 
the synthesis into PI in these mobile structures. Further study on these dynamic compartments 
is required preferably in other cell types.  
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Phosphatidylinositol 4-kinase 
Of the four PI 4-kinases encoded in the mammalian genome (PI4KIII (Stt4 in yeast), 
PI4KIII (Pik1 in yeast), PI4KII and PI4KIILsb6 in yeast), PI4KIII has recently been 
shown to be the isoform localized at the plasma membrane [103-105]. The role of PI4KIII 
in regulating PI4P synthesis during PLC signalling was first studied using pharmacological 
inhibitors and siRNA [103]. In this setting, the role of PI4KIII in regulating PI4P synthesis 
during PLC signalling has been studied in the context of overexpressed GPCRs; the role of 
this enzyme in the context of an endogenous G-protein coupled PLC pathway remains to be 
demonstrated. Also, the identity of the PI4K that regulates PI4P synthesis during Drosophila 
phototransduction remains to be established. 
 
An interesting feature of PI4KIII that has emerged from recent studies is that in multiple 
systems the enzyme exists as part of a protein complex. In yeast, the PI4KIII ortholog, Stt4 
exists as part of a complex consisting of three adaptor proteins, the peripheral membrane 
protein, EFR3, the scaffolding protein, Ypp1 (TTC7 in mammals) and an integral membrane 
protein Sfk1 (TMEM150A in mammals); this has also been observed in mammalian cells 
[105;106]. Efr3 is palmitoylated and is targeted to the plasma membrane due to a basic 
surface patch and by interactions with TMEM150A and recruits the PI4KIII/TTC7 complex 
by binding to the C-terminus of Efr3 [107]. Collectively, these studies also strongly suggest 
that PI4KIII is localized at the PM and the synthesis of PI4P occurs at this location. More 
recently, the leukodystrophy protein FAM126A (also known as hyccin) has also been shown 
to regulate PI4P synthesis and binds to TTC7 and possibly PI4KIII as well [108]. These 
findings suggest that the generation of PI4P by PI4KIII is a highly regulated process 
controlled by multiple proteins; this remains to be understood. Recent studies also indicate 
that in mammalian cells, protein kinase C can stimulate PI4K activity and so increase PI4P 
levels [109;110]. 
 
 
PIP 5-kinase 
Phosphorylation of PI4P to PI(4,5)P2 is catalysed by PIP 5-kinase (PIP5K). In the 
mammalian genome, there are three genes (PIP5K, -, and –) encoding PIP5K enzymes 
that are recruited at the plasma membrane as homodimers or heterodimers [111]. One of the 
striking features of the PIP5Ks is that in vitro, their activity can be enhanced by PA [112]. 
This positive feedback by PA may in part ensure that PI(4,5)P levels are restored promptly 
since PI(4,5)P2 is important for other functions including maintenance of the actin 
cytoskeleton. PIP5Khas a number of splice variants and one specific splice variant, 
PIP5K87 was found to be responsible for the generation of PI(4,5)P2 utilised to make IP3 in 
histamine-stimulated HeLa cells [113]. In a separate study, PIP5K was found to be 
responsible for thrombin-stimulated IP3 generation in platelets [114]. Mice deleted of 
PIP5K or  are born and develop normally indicating that PIP5K suffices to maintain 
PI(4,5)P2 levels. Mice deleted of PIP5Kon the other hand, die shortly after birth due to 
defects in neuronal function.  In the Drosophila genome, there are two PIP5K genes, sktl and 
dPIP5K. dPIP5K appears to be equivalent to mammalian PIP5K; it is enriched in the adult 
head and appears to regulate PI(4,5)P2 resynthesis during phototransduction [115]. By 
contrast, loss of sktl is lethal during development and is also cell-lethal in multiple tissues 
where this has been tested [[116] and P.Raghu lab, unpublished]. Although some isoforms of 
PIP5K have been reported at intracellular membranes, the vast majority of isoforms across 
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multiple species are localized to the plasma membrane. Thus the synthesis of PI(4,5)P2 from 
PI4P occurs primarily at the PM.  
 
 
Topological constraints in the PI(4,5)P2 cycle  
Activation of both G-protein-coupled receptors and receptor tyrosine kinases stimulates the 
PLC signalling pathway to hydrolyze PI(4,5)P2 and generate the two ubiquitous second 
messengers, IP3 and DG in almost all metazoans. The activity of PLC is auto-inhibited and 
external cues lead to its activation [117;118]. The substrate, PI(4,5)P2 is mainly localised at 
the PM and when cleaved by PLC, generates a series of lipid-soluble intermediates that are 
spatially restricted to and cannot diffuse away from the membrane at which they are 
generated. The immediate lipid product of PLC activity is DG that is rapidly converted into 
PA by DGK; these two reactions are thought to occur at the PM in mammalian cells (Fig. 
1B). PA is converted to PI by the action of two sequentially acting enzymes, CDS and PIS 
which are localized to the ER. This separation of PA generation at the PM from the enzyme 
that metabolizes it, CDS at the ER membrane constitutes a topological problem necessitating 
the need to transfer PA from the PM to the ER (Fig. 1B).  
 
The final steps in the PI(4,5)P2 cycle are the sequential phosphorylation of PI at the 4, and 5 
position to regenerate PI(4,5)P2 (Fig. 1B). The kinases that mediate the phosphorylation of PI 
to PI4P are not present in the ER but thought to reside at the PM, once again generating a 
spatial separation of non-diffusible substrate from the enzymes. To maintain PI(4,5)P2 
homeostasis following PLC signalling, the first question to be addressed is the subcellular 
distribution of PI and how changes in PI levels reflect changes in PI(4,5)P2 levels. PI 
distribution in cells has been monitored by subcellular fractionation and the majority of PI is 
found intracellularly, notably at the ER [119;120]. Unlike probes available for detecting the 
spatial distribution of phosphorylated PIs, no probes for monitoring the spatial distribution of 
PI has been identified so far. When PIS, an ER localized enzyme was knocked down, a 40% 
loss of total PI was noted and this was accompanied by a corresponding decrease in both 
PI4P and PI(4,5)P2 indicating that PI, PI4P and PI(4,5)P2 were in equilibrium and changes 
reflected in PI manifested itself in the total pool of phosphoinositides [85]. Thus in PIS 
knockdown cells, changes in PI synthesis at the ER are reflected in changes in plasma 
membrane PI(4,5)P2 reflecting the dependence of plasma membrane PI(4,5)P2 synthesis on 
the availability of PI from the ER. Since it is generally the case that hydrolysis of PI(4,5)P2 
manifests itself as a reduction in the PI pool [34;121-123], this would imply that the plasma 
membrane depends on PI being made available from the ER. Indeed, in permeabilised cells 
when PLC activation is intensely-driven, the amount of IP3 produced far exceeds the resting 
levels of PI(4,5)P2 and more importantly, a reduction in PI and not PI(4,5)P2 is mainly 
observed [121]. Essentially, hydrolysis of PI(4,5)P2 is dependent on on-going conversion of 
PI(4,5)P2 from PI.  
 
To demonstrate that PI at the ER contributes to PI(4,5)P2 synthesis at the plasma membrane 
in intact cells, a bacterial phospholipase C was targeted to the ER to deplete PI in this 
compartment and noted that recovery of PI(4,5)P2 at the plasma membrane was delayed 
following PLC activation [85;124]. Studies by Dickson et al have recently suggested that 
PI4P at the Golgi participates in the maintenance of the plasma membrane PI(4,5)P2 [125]. 
Targeting of a PI4P phosphatase, Sac1, to the Golgi or the PM led to a decrease in PM 
PI(4,5)P2. They suggested that 30% of the PM PI(4,5)P2 is derived from a Golgi PI(4)P pool 
under steady state. In these studies, the KCNQ2/3 current was monitored as an indirect 
measure of PI(4,5)P2 content. They suggest that Golgi-derived vesicles are responsible for 
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this transport. However, a recent study examined this question and concluded otherwise. The 
Golgi was disrupted using brefeldin A and under these conditions PI(4,5)P2 synthesis at the 
PM (as monitored by the translocation of the PH domain of PLC) was enhanced [124] and 
not reduced as expected. Thus from this data it is clear that PI originating from the ER is the 
precursor lipid for PI(4,5)P2 synthesis at the PM. Since the on-going production of IP3 in 
permeabilised cells was dependent on the presence of a PI transport protein, this would 
suggest a supply of PI from the ER to the plasma membrane. In this experimental condition, 
any protein that has PI transfer activity was capable of supporting PLC signalling. Thus 
PITP, PITP and even yeast Sec14p which has no structural or sequence identity to 
mammalian PITPs, were capable of supplying PI in these artificial conditions [126;127]. 
What these experiments establish is that the endoplasmic reticulum is the main source of PI 
and moreover, it has to be transported to the plasma membrane.  
 
 
Bridging the topological constraints in the PI(4,5)P2 cycle 
Conceptually, one of the ways of bridging the topological gap in the PI(4,5)P2 cycle would be 
the use of lipid transport proteins that would move lipid molecules between the ER and PM 
across the aqueous cytosol. This process could also be further optimized if one were to use 
sites where the ER and PM come in close contact with each other, namely the ER-PM MCS 
(membrane contact sites). A brief introduction to the current state of ER-PM contact sites is 
given below and we then discuss lipid transfer proteins in the context of the PI(4,5)P2 cycle.  
 
ER-PM contact sites 
The components of the PI(4,5)P2-PLC cycle are distributed in two membrane compartments, 
the ER and PM (Fig. 1B). Recent studies indicate that these two compartments can come into 
close proximity allowing lipid exchange to occur. The endoplasmic reticulum (ER) exhibits a 
complex network of tubules and cisternae continuous with the nuclear membranes and is 
involved in vesicular transport, protein synthesis, Ca2+ storage and lipid metabolism [128-
130]. It is also the largest organelle of the cell representing nearly 50% of the total cellular 
membranes [131]. The ER can be closely opposed to other organelle membranes including 
endosomes, peroxisomes, mitochondria in addition to the plasma membranes. These ER-PM 
membrane contact sites (MCS) have been by observed by electron microscopy (EM) in both 
mammalian cells e.g. in muscle cells, neurons and in fly photoreceptors [74;132;133].   
 
To maintain regions of close membrane contact tethering proteins that bring the membranes 
together are necessary. The distance between the ER and the PM at ER-PM contact sites is 
estimated to be in the range of 10 to 20 nm, sufficiently close to allow proteins in one 
compartment to directly interact with proteins or even lipids in the other compartment. 
Several tethering proteins have been identified in the formation of ER-PM contact sites. 
These include the junctophilins, Ist2 in yeast (related to TMEM16 proteins in mammals), 
VAMP-Associated Proteins (VAPs) (Scs2 and 22 in yeast) and most recently the Extended 
synaptotagmins (E-Syts; Tricalbins in yeast). These proteins are all anchored in the ER and 
many have domains allowing them to bind lipids on the PM in trans [130;134-136]. The 
junctophilins are necessary for sarcoplasmic reticulum (SR)-PM junctions in muscle cells 
[137], whereas VAPs are involved in numerous interactions at ER-PM contact sites, notably 
with oxysterol-binding (OSBP)-related protein (ORP) and PITPNM family members. VAPs 
bind to a FFAT motif on LTPs such as ORPs and PITPNMs. E-Syts are transmembrane 
proteins with multiple C2 domains and are tethered at the ER whereas the C2 domains 
interact with plasma membrane PI(4,5)P2. In yeast approximately 40% of the PM contacts the 
ER whilst in mammalian cells, ER-PM contacts are less prominent; in many non-excitable 
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cells less than 1% of the PM makes contact with the ER. In yeast, combined deletion of the 
six potential yeast ER-PM tethering proteins, Ist2, the VAP homologs Scs2/22, and all three 
Tricalbins was necessary to eliminate ER-PM junctions [138].  
 
In mammalian cells, membrane contact sites can be induced during Ca2+ signalling e.g. as it 
occurs with Stim and Orai [139;140]. Depletion of ER Ca2+ stores by IP3 binding to the IP3 
receptor on the ER leads to the process whereby store-operated calcium entry (SOCE) can 
occur. In brief, the Ca2+ sensors, STIM1 and STIM2 detect the decrease in Ca2+ in the ER 
stores and this causes a conformational change in STIM proteins such that they expose the 
SOAR domain, resulting in STIM redistribution to ER-PM contact sites where they assemble 
with the plasma membrane-localised Orai1, which is the store-operated Ca2+ channel [141].  
This transition is aided by an ancillary protein, STIMATE (TMEM110) which stabilises the 
ER-PM contact sites [142;143].  
 
In mammalian cells, ER-localised E-Syts have recently been identified as tether proteins that 
bind to the plasma membrane upon elevation of Ca2+ [144]. E-Syts are a family of ER 
integral membrane proteins with multiple C2 domains that are conserved from yeast to 
mammals. E-Syts contain an amino- terminal ER-membrane anchor, an SMP 
(synaptotagmin-like mitochondrial-lipid binding protein) domain and multiple C2 domains. 
The E-Syt family has three members; E-Syt1 has five C2 domains and E-Syt2 and E-Syt3 
each have three C2 domains (Table 2). C2 domains are independently folded domains that 
can mediate Ca2+/phospholipid interactions. The SMP domains belong to the TULIP 
superfamily of lipid/hydrophobic ligand binding domains [145;146] and the SMP domain of 
E-Syt2 has a -barrel structure and dimerizes to form an approximately 90 ngstrom long 
cylinder traversed by a channel lined entirely with hydrophobic residues. The channel can 
accommodate lipids with the lipid fatty acid tails embedded in the hydrophobic channel 
whereas the polar headgroup protrudes in the aqueous phase. The SMP channel lacks 
specificity and binds any glycerolipids without any discrimination but does not bind 
cholesterol, sphingomyelin or ceramide [147;148]. The C2 domains of E-Syt2 /3 interacts 
with plasma membrane PI(4,5)P2 thus tethering the ER to the plasma membrane. Tethering of 
E-Syt1 to the plasma membrane is more complex; it occurs when Ca2+ is elevated and is 
dependent on the C2C domain of E-Syt1 [149]. In the presence of Ca2+ this domain binds to 
PI(4,5)P2. Since hydrolysis of PI(4,5)P2 by PLC causes a rise in Ca
2+, E-Syt1 localises to the 
PM, but only transiently due to hydrolysis of PI(4,5)P2 [144;150].   
 
E-Syt1 can apparently use their SMP domain to transfer lipids between two membrane 
compartments in vitro provided that the C2C domain is intact. Mutations in the Ca2+ binding 
sites abrogate tethering as well as lipid transfer. Thus E-Syt1 is a Ca2+-dependent lipid 
transfer protein that functions at membrane contact sites [150;151]. Unlike other LTPs 
described later, SMP domains do not bind a single lipid like LTPs but forms a channel and 
can transfer any glycerolipid. 
 
 
PI transfer proteins 
Given the distribution of lipid intermediates of the PI(4,5)P2 cycle between the PM and the 
ER, it is essential for cells to have in place a mechanism that allows the exchange of lipid 
intermediates between these two compartments (Fig. 1B). Given the rapid rates that PLC 
signalling can achieve in vivo, transfer of lipid intermediates via vesicular transport is likely 
to be a slow and unwieldy solution. The use of lipid transport proteins (LTPs) is a potential 
solution for the exchange of such lipid intermediates. Multiple families of lipid transport 
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proteins (LTPs) have been identified in eukaryotic cells that can engage in non-vesicular lipid 
transport. LTPs fall into two categories: they can be either single domain cytosolic proteins or 
they can be multi-domain proteins with an LTP domain. To date, intracellular families of 
LTPs include START, OSBP, CRAL-TRIO, GLTP and PITP. The hallmark of all LTPs is 
their ability to accommodate a lipid within a hydrophobic cavity and shield it from the 
aqueous environment. Structures are available for many of the LTPs showing the lipid-
protein interactions that take place to hold the lipid in position during transport between 
membranes [152]. These structures reveal that the entrance to the cavity is blocked by a 
flexible ‘lid’. In mammalian cells, the PITP family has been identified as the main LTP that 
can bind and transfer PI and therefore are the pertinent LTPs in ensuring a supply of PI for 
PI(4,5)P2 synthesis during PLC signalling [153;154].  
 
 
PITP overview 
Since the original discovery of PITPs as a biochemical activity that can mediate PI transfer 
between membranes in vitro [7] and support PLC signalling in vivo, a large number of genes 
encoding PITPs have been discovered in metazoa through both molecular cloning and 
genome sequencing efforts. In the mammalian genome, there are five genes that encode 
proteins with a PITP domain; these are subdivided into two classes based on sequence 
homology as well as their lipid binding characteristics [155;156] (see Table 1 and Fig. 2)) 
Class I PITPs, PITP and PITP are single domain PITPs and can bind and transfer PI or PC 
whilst Class II PITPs are proteins that can bind and transfer PI and PA, both of which are 
lipid intermediates that need to be exchanged during the PI(4,5)P-PLC cycle. Class II PITPs 
comprise three members; PITPNC1, PITPNM1 and PITPNM2. The founding member of the 
Class II PITPs is Drosophila retinal degeneration B (RDGB), a multi-domain protein with a 
N-terminal PITP domain [157]. The N-terminal PITP domain of RDGB is followed by a 
region of low complexity, a FFAT motif, a DDHD domain and a LNS2 domain (Fig. 2). The 
FFAT motif can bind to the ER-resident integral protein, VAP. A third member of the 
PITPNM family is PITPNM3 that lacks the PITP domain. PITPNM3 also contains the FFAT 
motif and could potentially be a negative regulator by competing to bind with VAP. The 
structural arrangements of the different domains in PITPNM1 and 2 are not known but one of 
the key questions that need to be addressed is whether the PI transfer activity of the PITP 
domain is kept inhibited by protein interactions and only made accessible after PLC 
activation. An acidic region has been shown to bind Ca2+ and therefore changes in cytosol 
Ca2+ could potentially influence the structure [157;158]. In addition to PITPNM, Class II also 
includes the short Class IIB PITPs (RdgB, PITPNC1).  
 
Table 1 provides a summary of the PITP proteins and the various nomenclatures in use. We 
propose that the HUGO nomenclature (PITPNA, PITPNB, PITPNM and PITPNC1) for the 
gene names should be adopted for the corresponding proteins and will be used throughout 
this review. Recent studies in both mammalian cells and in Drosophila converge to suggest 
that, the PITPNM proteins are the long sought for proteins that can facilitate the transfer of PI 
and PA between the PM and the ER at membrane contact sites (MCS) during the PLC-
PI(4,5)P2 cycle.  
 
Biochemical properties of the PITP domain  
 (a) PI transfer function: The PITP family of proteins are well-characterised with respect to 
their lipid binding specificities. PITPs have dual specificity. The first PITP protein to be 
identified, PITP, was shown to be present in two complexes when purified from brain; 
PITP bound to either PI or to PC [7;8]. The PITP-PI (or PC) complex is stoichiometric, 
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involving a single lipid molecule [159;160]. The binding pocket can accommodate either a PI 
or a PC molecule; whilst the phosphate moiety and the two lipid tails occupy identical 
positions, the headgroup makes contact with different amino acids. The inositol headgroup 
makes contact with four amino acid residues (T59, K61, E86 and N90) and these residues are 
conserved in all PITPs. Mutation of any of these amino acids leads to loss of PI binding and 
transfer but has little effect on PC binding and transfer. The PI and PC bound forms are 
readily convertible by incubating with excess lipid and can be separated based on charge; the 
PI-PITP complex is more negative that the PC-PITPNA complex [161]. The lipid-bound 
forms of PITPs have a ‘closed’ conformation whilst the apo-form has an ‘open’ 
conformation. The apo-form is only transiently observed during lipid exchange at the 
membrane [152]. A recent study has shown that these key determinants of PI binding and 
transfer activity are also conserved in PITPNM1 when tested both in vitro [127] and in vivo 
[127;149].  
 
 
(b) PA transfer function: In contrast to PITP, the PITP domain of Drosophila PITPNM1 
does not transfer PC; rather it binds and transfers PA [127]. The PITP domains of PITPNM 
proteins bind PI at much higher levels compared to Class I PITPs and can also bind PA but 
not to the same extent as PITPNC1. PITPNC1 is a cytosolic protein with a PITP domain 
followed by an unstructured 80 amino acid C-terminal tail. PITPNC1 bound similar amounts 
of PI and PA despite the fact that PA constitutes less than 1% of the total lipids suggesting a 
very affinity for PA binding [10]. Recent studies have shown that the isolated PITP domain 
of human PITPNM1 or Drosophila PITPNM was able to transfer PA between membrane 
compartments in vitro very efficiently [156].  
 
An independent study also analyzed the ability of PITPNM1 to remove PA from the plasma 
membrane to the ER, in HEK cells expressing the Ang II receptor [162]. Using a PA reporter, 
these authors followed the decrease in cytoplasmic fluorescence as the PA probe translocated 
to the plasma membrane upon Ang II stimulation. In cells that co-express PITPNM1 the PA 
probe was removed from the plasma membrane faster than in the surrounding cells not 
expressing the probe. From these experiments, the authors concluded that over-expression of 
PITPNM1 facilitates the removal of PA from the plasma membrane.  The PITP domain was 
required for PA removal. Mutation of T59 to A or E of the PITP domain of PITPNM1 
prevented PA clearance following stimulation. Unfortunately no analysis of the PA transfer 
and binding activity of these mutants in vitro were provided. The structure of the PITP 
domain of PITP coupled with mutational analysis has identified that T59 is in the binding 
pocket and is important for PI binding and transfer. In PITP, T59 when mutated to E is 
unable to transfer PI but when mutated to A retains partial transfer activity [159;161]. This is 
also the case for the PITP domain of Drosophila PITPNM1. Thus it is surprising that the 
T59A mutant completely prevented PA clearance following stimulation. Analysis of PA 
transfer in vitro of the two mutants shows that it was unaffected [127]. This result is not 
surprising because T59 only makes contact with the inositol ring and does not contribute to 
the binding of the phosphate moiety in the binding pocket. A detailed analysis of the PITP 
domain of the human PITPNM protein is warranted to clarify these discrepancies. 
Identification of mutants that are defective in PA but not PI transfer would assist in this 
analysis. One of the key questions is how the PITP domain accommodates PA in the lipid 
binding cavity. It is interesting to note that PITPNC1 which can bind PA extremely well but 
transfer PA less efficiently was without effect in clearing PA from the plasma membrane 
[162]. In contrast, the PITP domain of PITPNM1 alone was still partly functional indicating 
that membrane contact sites make the transfer more efficient.  
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Spatial organization of PITPNM in relation to function 
 
(a) PITPNM proteins are membrane-associated proteins  
In Drosophila PITPNM, the founding member of the PITPNM family, early work had 
identified multiple hydrophobic segments downstream of the PITP domain and it was 
speculated that they could act as trans-membrane spanning segments [157]. Subsequently, 
PITPNM proteins were also identified in mammals where two separate genes encoding for 
PITPNM1 and PITPNM2 were identified [163;164]. A study by Lu et al, investigated 
whether PITPNM2 was an integral membrane protein [164]. They performed subcellular 
fractionation studies and found that although PITPNM2 was associated with the membrane 
pellet, conditions that disrupt protein–protein interactions, such as 1 M NaCl, high pH, or 
strong denaturants such as urea or guanidine, solubilized PITPNM2 partially or completely. 
In contrast, the detergent Triton X-100 failed to solubilize any PITPNM2. Thus PITPNM2 
did not behave as an integral membrane protein. Similar studies conducted with Drosophila 
PITPNM confirmed that the protein is membrane-associated and can be solubilised under 
conditions that disrupt protein-protein interactions confirming that endogenous PITPNM 
proteins are not integral or cytosolic proteins but are membrane-associated [127]. 
 
In 2000, a zebrafish PITPNM homolog (alt names: PITP-less RdgB, pl-RdgB, PITPNM3) 
that lacks the amino-terminal PITP domain, was identified [165]. PITPNM3 is also present in 
mammals but not in Drosophila. The mouse PITPNM3 shares over 45% amino acid identity 
with the two mouse PITPNM proteins (PITPNM1 and 2) and was also found to be 
membrane-associated; it could be released when membranes were treated with the protein 
denaturant, guanidine. In contrast, Triton X-100 which solubilises the membranes did not 
solubilise the protein but was found in the pellet likely associated with the cytoskeleton. 
Similar experiments have also been conducted for PITPNM1 and it was concluded that 
PITPNM proteins are not integral membrane proteins, but may associate with the membrane 
through protein–protein interactions [166]. Thus three independent studies on different 
PITPNM proteins concluded that they are membrane-associated proteins [164-166] and not 
integral membrane proteins as originally suggested [157]. Thus it comes as a surprise that 
PITPNM3 has been recently identified as a transmembrane receptor for the chemokine, 
CCL18 [167;168]. It was proposed that extracellular CCL18 binds to PITPNM3 and can 
activate signal transduction pathways including PI3K [169]. This finding has been recently 
challenged however [170] and we suggest that PITPNM proteins are membrane-associated 
proteins rather than integral proteins and it is unlikely that PITPNM3 is a transmembrane 
receptor for the chemokine, CCL18. Determinants that mediate membrane association of 
PITPNM proteins include interactions between the FFAT motif with the integral VAP 
proteins as well as the LNS2 that can interact with PA as reported recently.   
 
 
(b) Localization of PITPNM proteins to membrane contact sites 
Recent studies indicate that the transfer of PI from the ER to the PM takes place at membrane 
contact sites by PITPNM1. PITPNM1 was found to translocate to ER-PM contact sites 
following PLC activation by histamine [149;162]. Secondly, knockdown of PITPNM1 
resulted in decreased recovery of PI(4,5)P2 at the PM whilst over-expression enhanced 
recovery. The PI transfer activity was essential for PI(4,5)P2 replenishment as mutation of 
key residues that abolished PI transfer were not functional although they still translocated to 
the ER-PM contact sites. It is interesting to note that knockdown of PITPNM1 did not inhibit 
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the initial loss of PI(4,5)P2 following histamine stimulation indicating that basal levels of 
PI(4,5)P2 were not affected by loss of PITPNM1. This is in contrast to what is observed in 
Drosophila photoreceptors, where deletion of PITPNM led to a pronounced decrease in 
resting PI(4,5)P2 levels [127].  
 
In mammalian cells there are two PITPNM proteins and it is suggested that these two 
proteins have subtle differences in PI(4,5)P2 replenishment at the plasma membrane. 
PITPNM2 is more sensitive and functions at low levels of PI(4,5)P2 hydrolysis whilst 
PITPNM1 restores PI(4,5)P2 homeostasis at intense levels of stimulation [124]. This was 
demonstrated by the use of two inhibitors, U73122 (PLC inhibitor) and R59022 (DGK 
inhibitor). Both drugs inhibited the translocation of PITPNM2 to the PM. Although U73122 
has been used in the literature as a PLC inhibitor, it is clear that it is NOT a direct inhibitor of 
phospholipase C enzymes. U73122 is a cationic amphiphilic drug and very likely decreases 
the availability of the PI(4,5)P2 substrate [171]. This would affect PI(4,5)P2 interactions with 
the cytoskeleton as well. Likewise R59022 only inhibits the Type I DGK and  and 
moderately inhibits type II and [172]. In mammalian cells there are 10 DGK subdivided 
into 5 classes (see Table 2 and [60]) and Type III DGK which is specific for arachidonyl 
stearoyl DG is not inhibited by this inhibitor. Identification of the DGK responsible for 
conversion of PLC-derived DG to PA will assist in clarifying the situation.  
 
What drives the translocation of PITPNM1 to ER-PM contact sites? Translocation to ER-PM 
contact sites requires PITPNM protein to be associated with the ER and the plasma 
membrane simultaneously. Several studies have shown that PITPNM1 is localised to the ER 
and translocated to ER-PM contact sites following PLC activation [124;149;162]. Moreover, 
co-expression of VAP-B increased the ER association of PITPNM1 and upon stimulation 
both proteins clustered and co-localised at membrane contact sites. It is interesting to note 
that CDS2 was also found in the same clusters [162]. 
 
Association with the ER is dependent on the FFAT motif that binds to ER-localised VAP 
proteins. This is supported by studies in HeLa cells where PITPNM1 mutated at FFAT 
binding motif failed to get recruited at ER-PM contacts [149;162]. Recruitment of PITPNM1 
was dependent on prior recruitment of E-Syt1 that decreased the distance between the ER-
PM contacts [149]. Thus these results suggested that the increase in cytosol Ca2+ following 
PLC activation results in E-Syt1 recruitment which reduces the distance between the two 
membranes allowing PITPNM1 to bridge the GAP with the FFAT motif facilitating ER 
association. In this scenario, it is suggested that PITPNM1 can promote the transfer of PI for 
PI(4,5)P2 replenishment after receptor-induced hydrolysis via its PITP domain [149]. The 
main evidence to support this can be summarised [149]: (1) Downregulation of E-Syt1 results 
in a delay in the kinetics of PI(4,5)P2 resynthesis measured using fluorescent reporters for this 
lipid (2) knockdown of PITPNM1 leads to a decrease in PI(4,5)P2 replenishment as 
monitored by measuring the dynamics of PI(4,5)P2 reporters (iii) over-expression of 
PITPNM1 enhances PI(4,5)P2 replenishment via PI binding to the PITP domain. These 
findings suggest that ER-PM MCS may support the PI(4,5)P2 cycle. The effect of reducing 
MCS function on clearing PA from the PM is not known.   
 
Saheki et al have examined the recruitment of endogenous E-Syt1 to ER-PM contacts and 
report that whilst ionomycin or thapsigargin rapidly translocated E-Syt1, the translocation 
observed with oxotremorine as a stimulus was transient. Since E-Syt1 binds to PI(4,5)P2 at 
the membrane in a Ca2+ dependent manner, the pronounced decrease in PI(4,5)P2 by 
oxotremorine is likely responsible for the transient nature of E-Syt1 recruitment [150].  
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In one study, a synthetic construct, MAPPER (membrane-attached peripheral ER) was used 
that selectively monitors ER-PM contact sites. The MAPPER construct comprises of a signal 
peptide, GFP, transmembrane segment, a linker, FRB (FKBP12-rapamycin binding) domain, 
a linker followed by phosphoinositide binding (PB) domain. Essentially the TM resides in the 
ER whilst the PB domain can bind to PI(4,5)P2 at the PM. It was found that the increase in 
cytosol Ca2+ increased ER-PM junctions and this was dependent on the translocation of E-Syt 
to the junctions [149]. Ca2+-dependent translocation of E-Syt1 to ER-PM junctions has also 
been demonstrated by another study [144]. 
 
To examine how PITPNM proteins sense PI(4,5)P2 hydrolysis, and translocate to the ER-PM 
contact sites, it was shown that the LNS2 domain of PITPNM1 is recruited by increases in 
PA [173]. During cell stimulation of cell–surface receptors, many agonists stimulate both 
phospholipase C and phospholipase D. Both phospholipases produce PA; PLD produces PA 
directly whilst PLC produces DG that is rapidly phosphorylated to PA by DG kinase. A 
commonly-used PLC inhibitor, U73122 was found to inhibit translocation of PITPNM1 to 
the ER-PM contact sites as was a DG Kinase inhibitor, R59022 suggesting that phospholipase 
C was the main source of PA [162].   
 
However in HeLa cells, endogenous PITPNM1 was found to be localised to the Golgi in 
interphase cells and translocated from the Golgi to the PM upon stimulation with EGF [173]. 
Localisation to the Golgi required the PITP domain whilst translocation to the plasma 
membrane required the C-terminal LNS2 domain (a.a. 911-1244). The LNS2 domain has 
been identified in lipins (PA phosphatase) and is the catalytic domain; however, in PITPNM 
proteins, a critical residue is substituted by a serine meaning that PITPNM would lack 
intrinsic PA phosphatase activity but could bind PA. Both exogenous addition of PA or 
stimulation of phospholipase D activity led to the translocation of PITPNM1 to the plasma 
membrane. The isolated LNS2 domain was found to bind liposomes when PA was present. 
Over-expression of PITPNM1 was found to enhance EGF-stimulated Akt phosphorylation 
whilst knockdown reduced EGF-stimulated Akt phosphorylation [173]. The effects of 
PITPNM1 on Akt required both the PITP domain as well as the LNS2 domain. Additional 
studies showed that PITPNM1 regulated both PI(4,5)P2 and PI(3,4,5)P3 levels and this 
required both the PITP domain intact for PI transfer and also the LNS2 domain that could 
bind PA. The main conclusion from this study was that PITPNM1 could translocate to the 
plasma membrane upon increases in PA levels and that the PITP domain transferred PI to the 
plasma membrane [173].  
 
In contrast to mammalian tissue culture cells, in Drosophila photoreceptors, the single 
PITPNM is constitutively localized at the SMC a MCS between the ER and the PM [74]. 
There is no detectable change in this localization on receptor stimulation. However it is 
possible that there are subtle changes or rearrangements in 3D conformation between the 
various domains of PITPNM thus regulating lipid transfer function. These remain to be 
discovered. 
 
 
Concluding remarks 
In this review, we put the PITPNM proteins as major players in moving PI and PA during the 
resynthesis of PI(4,5)P2 after PLC signalling (Fig. 2). We answer the major outstanding 
question that was highlighted in the review by Michell in 1975 [3]. A neat solution is found 
by identifying a single protein that can accomplish reciprocal transfer of PA for PI to 
 20 
 
complete the ‘PI cycle’. An important feature that emerges is that lipid transfer takes place at 
privileged sites where the ER and the plasma membrane come into close proximity such that 
lipid exchange occurs over very short distances. One outstanding question that remains is the 
structures of the different domains of the PITPNM proteins. This will shed light on whether 
the PITP domain is held in an inactive state and only becomes operational during PLC 
signalling. A second question is to identify key residues in the PITP domain of the PITPNM 
proteins that are important for PA binding as these mutants will facilitate in further testing of 
the model.  
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Gene name Full name Protein 
name 
Synonyms 
PITPNM1 phosphatidylinositol transfer 
protein membrane-associated 1 
PITPNM1 Nir2,  
RdgB1, 
PITPNM2 phosphatidylinositol transfer 
protein membrane-associated 2 
PITPNM2 Nir3, 
RdgB2, 
PITPNM3 PITPNM family member 3 (lacks a 
PITP domain 
PITPNM3 Nir1, 
RdgB3, 
pI-RdgB, 
PITPNC1 phosphatidylinositol transfer 
protein, cytoplasmic 1 
PITPNC1 RdgB, 
PITPNA phosphatidylinositol transfer 
protein alpha 
PITP PITPNA 
VIB1A 
PITPNB phosphatidylinositol transfer 
protein beta 
PITP PITPNB 
VIB1B 
 
Table 1: Nomenclature of PITP proteins in common use 
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Enzymes of the PI(4,5)P2 cycle Mammals D.melanogaster 
Phospholipase Cs 
PLC 
PLC 
PLC 
PLC 
PLC 
PLC 
13 
PLC1; 2; 3; 4  
PLC1; PLC2 
PLC1; 3; 4; 
PLC 
PLC 
PLC2; 
3 
norpA (CG3620); PLC21C (CG4574) 
PLCCG 
Diacylglycerol kinase 
Type I 
Type II 
Type III 
Type IV 
Type V 
10 
DGK, DGK, DGK,  
DGK, DGK,DGK,  
DGK,  
DGK, DGK,  
DGK 
5 
Dgk (CG34361),  
CG31187, 
DGKCG8657) 
rdgA(CG42667), 
CG31140, 
CDP-diacylglycerol Synthase 
 
 
3 
Cds1; Cds2; 
Tam41 
2 
Cds (CG7962) 
Tam41 (CG33331) 
PI Synthase 1 
PIS 
1 
PIS (CG9245) 
Class I PITPs 
 
2 
PITP; PITP 
1 
PITP (vib) (CG5269) 
Class II PITPs (RdgB) 
IIA 
IIB 
3 
PITPNM1; PITPNM2;  
PITPNC1 
2 
RdgB (CG11111);  
RdgB (CG17818) 
Phosphatidylinositol 4-kinase 
Type II PI4K 
TypeIII PI4K 
4 
PI4KIIA, PI4KIIB  
PI4KIIIA, PI4KIIIB, 
3 
PI4KIIA (CG2929); 
PI4KIIIA (CG10260); fwd, (PI4K3B; CG7004) 
 
PIP 5-kinase 
 
3 
PIP5K1A; PIP5K1B, PIP5K1C
2 
Sktl (CG9985); dPIP5K (CG3682) 
E-Synaptotagmin 3 
E-Syt1; E-Syt2; E-Syt3 
1 
E-Syt2 (CG6643),  
VAMP associated Protein (VAP) 2 
VAPA,  
VAPB 
3 
dVAP-A (CG5014),  
dVAP-B (CG33523),  
fan (CG7919) 
 
Table 2 Diversity in the enzymes of the PI(4,5)P2 cycle required for phospholipase C 
signalling:  Comparison between mammals and Drosophila.  
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Figure Legends  
 
Fig. 1 The ‘PI(4,5)P2 cycle’ : metabolic interconversions involved in resynthesis of 
phosphoinositides after hydrolysis by phospholipase C 
[A] The ‘PI cycle’ as proposed by Mabel and Lowell Hokin in 1964 [2].  
[B] Topological organization of the ‘PI(4,5)P2 cycle’: The ‘PI(4,5)P2 cycle’ operates between 
two membrane compartments, the ER and the PM requiring the transfer of PA and PI in 
opposite directions. The ‘PI(4,5)P2 cycle’ was routinely observed by monitoring the 
incorporation of 32Pi into PA and PI (phosphate labelled in blue).  
 
Fig. 2 Restoration of PI(4,5)P2 levels following phospholipase C signalling is 
accomplished by PITPNM proteins that can reciprocally transfer PA and PI at 
membrane contact sites.  
Model illustrating how PITPNM participate in PA and PI transfer at membrane contact sites 
for the restoration of PI(4,5)P2 levels. The ‘PITP domain’ is modelled on the structure of 
PITP. The ‘FFAT’ motif that binds to VAP is indicated. Participation of E-Syt in tethering 
the two membranes is not included in the diagram for clarity. Abbreviations are: MSP, major 
sperm protein homology domain; FFAT motif sequence, EFFDAxE; TM, transmembrane 
domain. 
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